SG Americas Securities’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19K | Sell |
|
|||||
|
2025
Q2 | $59K | Buy |
|
|||||
|
2025
Q1 | $27K | Sell |
|
|||||
|
2024
Q4 | $74K | Buy |
|
|||||
|
2024
Q3 | $120K | Sell |
|
|||||
|
2024
Q2 | $119K | Sell |
|
|||||
|
2024
Q1 | $275K | Sell |
|
|||||
|
2023
Q4 | $339K | Buy |
|
|||||
|
2023
Q3 | $156K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $63K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $324K | Sell |
|
|||||
|
2022
Q1 | $4.06M | Sell |
|
|||||
|
2021
Q4 | $24.6M | Buy |
|
|||||
|
2021
Q3 | $3.36M | Buy |
|
|||||
|
2021
Q2 | $4.61M | Buy |
|
|||||
|
2021
Q1 | $1.46M | Buy |
|
|||||
|
2020
Q4 | $262K | Sell |
|
|||||
|
2020
Q3 | $3.09M | Buy |
|
|||||
|
2020
Q2 | $151K | Sell |
|
|||||
|
2020
Q1 | $565K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $169K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $42K | Buy |
|